Document is current
Any future updates will be listed below
-
Authors
Wang, Lizhi
Xia, Junhao
Guan, Xin
Song, Yang
Zhu, Mengru
Wang, Fengya
Zhao, Baofeng
Liu, Lukuan
Liu, Jing
-
Funding
Funding for this research was provided by:
DMU-1&DICP (DMU-1&DICP UN202204)
the National Natural Science Foundation of China (22004012)
the Dalian High-level Talent Team Project (2022RG18)
the Liaoning Directed Project for Planning of Science and Technology (2021JH2/10300135)
- License Information
-
More Information
Article History
Received: 19 August 2024
Accepted: 26 October 2024
First Online: 10 November 2024
Declarations
:
: The use of human umbilical cord mesenchymal stem cells was approved by the Ethics Committee of the First Affiliated Hospital of Dalian Medical University (approval PJ-KS-KY-2023-97). All procedures were in compliance with the relevant guidelines and regulations.
: The authors confirm that the work described has not been published before, not under consideration for publication elsewhere. Its publication has been approved by all co-authors.
: The authors declare no competing interests.
